188 related articles for article (PubMed ID: 31650907)
1. Kinetic Analysis of Growth Activity in Enlarging Papillary Thyroid Microcarcinomas.
Ito Y; Miyauchi A; Kudo T; Higashiyama T; Masuoka H; Kihara M; Miya A
Thyroid; 2019 Dec; 29(12):1765-1773. PubMed ID: 31650907
[No Abstract] [Full Text] [Related]
2. Natural history of papillary thyroid microcarcinoma: Kinetic analyses on tumor volume during active surveillance and before presentation.
Miyauchi A; Kudo T; Ito Y; Oda H; Yamamoto M; Sasai H; Higashiyama T; Masuoka H; Fukushima M; Kihara M; Miya A
Surgery; 2019 Jan; 165(1):25-30. PubMed ID: 30413323
[TBL] [Abstract][Full Text] [Related]
3. Marked Decrease Over Time in Conversion Surgery After Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma.
Sasaki T; Miyauchi A; Ito Y; Kudo T; Kanemura N; Sano T; Kawano S; Yamamoto M; Fujishima M; Masuoka H; Higashiyama T; Kihara M; Miya A
Thyroid; 2021 Feb; 31(2):217-223. PubMed ID: 32664805
[No Abstract] [Full Text] [Related]
4. Effects of Pregnancy on Papillary Microcarcinomas of the Thyroid Re-Evaluated in the Entire Patient Series at Kuma Hospital.
Ito Y; Miyauchi A; Kudo T; Ota H; Yoshioka K; Oda H; Sasai H; Nakayama A; Yabuta T; Masuoka H; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
Thyroid; 2016 Jan; 26(1):156-60. PubMed ID: 26670937
[TBL] [Abstract][Full Text] [Related]
5. An observational trial for papillary thyroid microcarcinoma in Japanese patients.
Ito Y; Miyauchi A; Inoue H; Fukushima M; Kihara M; Higashiyama T; Tomoda C; Takamura Y; Kobayashi K; Miya A
World J Surg; 2010 Jan; 34(1):28-35. PubMed ID: 20020290
[TBL] [Abstract][Full Text] [Related]
6. Aggressive papillary thyroid microcarcinoma: prognostic factors and therapeutic strategy.
Ardito G; Revelli L; Giustozzi E; Salvatori M; Fadda G; Ardito F; Avenia N; Ferretti A; Rampin L; Chondrogiannis S; Colletti PM; Rubello D
Clin Nucl Med; 2013 Jan; 38(1):25-8. PubMed ID: 23242040
[TBL] [Abstract][Full Text] [Related]
7. Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate Surgery.
Oda H; Miyauchi A; Ito Y; Yoshioka K; Nakayama A; Sasai H; Masuoka H; Yabuta T; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
Thyroid; 2016 Jan; 26(1):150-5. PubMed ID: 26426735
[TBL] [Abstract][Full Text] [Related]
8. Insights into the Management of Papillary Microcarcinoma of the Thyroid.
Miyauchi A; Ito Y; Oda H
Thyroid; 2018 Jan; 28(1):23-31. PubMed ID: 28629253
[TBL] [Abstract][Full Text] [Related]
9. Association between serum thyrotropin concentration and growth of asymptomatic papillary thyroid microcarcinoma.
Sugitani I; Fujimoto Y; Yamada K
World J Surg; 2014 Mar; 38(3):673-8. PubMed ID: 24233662
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 cases.
Ghossein R; Ganly I; Biagini A; Robenshtok E; Rivera M; Tuttle RM
Thyroid; 2014 Feb; 24(2):245-53. PubMed ID: 23745671
[TBL] [Abstract][Full Text] [Related]
11. Natural History of Asymptomatic Papillary Thyroid Microcarcinoma: Time-Dependent Changes in Calcification and Vascularity During Active Surveillance.
Fukuoka O; Sugitani I; Ebina A; Toda K; Kawabata K; Yamada K
World J Surg; 2016 Mar; 40(3):529-37. PubMed ID: 26581368
[TBL] [Abstract][Full Text] [Related]
12. Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Microcarcinoma: A Multicenter Cohort Study in Korea.
Jin M; Kim HI; Ha J; Jeon MJ; Kim WG; Lim DJ; Kim TY; Chung JH; Shong YK; Kim TH; Kim WB
Thyroid; 2021 Oct; 31(10):1494-1501. PubMed ID: 34225475
[No Abstract] [Full Text] [Related]
13. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
14. Active Surveillance for Patients With Papillary Thyroid Microcarcinoma: A Single Center's Experience in Korea.
Kwon H; Oh HS; Kim M; Park S; Jeon MJ; Kim WG; Kim WB; Shong YK; Song DE; Baek JH; Chung KW; Kim TY
J Clin Endocrinol Metab; 2017 Jun; 102(6):1917-1925. PubMed ID: 28323932
[TBL] [Abstract][Full Text] [Related]
15. Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a mono-institutional experience.
Cappelli C; Castellano M; Braga M; Gandossi E; Pirola I; De Martino E; Agosti B; Rosei EA
J Surg Oncol; 2007 Jun; 95(7):555-60. PubMed ID: 17226813
[TBL] [Abstract][Full Text] [Related]
16. Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Carcinoma.
Oh HS; Kwon H; Song E; Jeon MJ; Kim TY; Lee JH; Kim WB; Shong YK; Chung KW; Baek JH; Kim WG
Thyroid; 2019 May; 29(5):642-649. PubMed ID: 30864894
[No Abstract] [Full Text] [Related]
17. Active Surveillance as First-Line Management of Papillary Microcarcinoma.
Ito Y; Miyauchi A
Annu Rev Med; 2019 Jan; 70():369-379. PubMed ID: 30230964
[TBL] [Abstract][Full Text] [Related]
18. Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance.
Tuttle RM; Fagin JA; Minkowitz G; Wong RJ; Roman B; Patel S; Untch B; Ganly I; Shaha AR; Shah JP; Pace M; Li D; Bach A; Lin O; Whiting A; Ghossein R; Landa I; Sabra M; Boucai L; Fish S; Morris LGT
JAMA Otolaryngol Head Neck Surg; 2017 Oct; 143(10):1015-1020. PubMed ID: 28859191
[TBL] [Abstract][Full Text] [Related]
19. Cervical lymphadenopathies signaling thyroid microcarcinoma. Case study and review of the literature.
Garrel R; Tripodi C; Cartier C; Makeieff M; Crampette L; Guerrier B
Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Jun; 128(3):115-9. PubMed ID: 21333620
[TBL] [Abstract][Full Text] [Related]
20. Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma: A Multi-Center Cohort Study in Korea.
Oh HS; Ha J; Kim HI; Kim TH; Kim WG; Lim DJ; Kim TY; Kim SW; Kim WB; Shong YK; Chung JH; Baek JH
Thyroid; 2018 Dec; 28(12):1587-1594. PubMed ID: 30226447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]